Since we found that MCP-1 impacts the AD risk of genetic variants in APOE and HLA-DRB1 differently(18), we hypothesized that blood MCP-1 might modulate the effects of other genetic variants on AD risk. Here, CCL2 is linked to Alzheimer disease.